Study to investigate the potential of probiotics in children attending school

European Journal of Clinical Nutrition

Volumn 65, Issue 4, 2011, Pages 447-453

  Merenstein, D ^a   Gonzalez, J ^a   Young, A G ^a   Roberts, R F ^b   Sanders, M E ^c   Petterson, S ^d  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c DAIRY AND FOOD CULTURE TECHNOLOGIES   (United States)

^d ROBERT GRAHAM CENTER   (United States)

Author keywords

daycare; infections; probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT; YOGHURT;

ACADEMIC ACHIEVEMENT; ARTICLE; BIFIDOBACTERIUM ANIMALIS; CHILD; COLONY FORMING UNIT; CONSTIPATION; CONTROLLED STUDY; DAY CARE; DIAPER DERMATITIS; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; HUMAN; HYPERACTIVITY; INFECTION; LACTOBACILLUS DELBRUECKII; LOOSE FECES; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RASH; STOMACH PAIN; STRAWBERRY; STREPTOCOCCUS THERMOPHILUS; UNITED STATES;

ABSENTEEISM; BEVERAGES; BIFIDOBACTERIUM; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DISTRICT OF COLUMBIA; DOUBLE-BLIND METHOD; FEMALE; FOOD, FORTIFIED; HUMANS; MALE; PROBIOTICS; SCHOOLS, NURSERY; SOCIOECONOMIC FACTORS; STEM CELLS; YOGURT;

BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; FRAGARIA X ANANASSA;

EID: 79953776109     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.290     Document Type: Article

References (37)

1. Abi-Hanna A, Moore N, Yolken R, Saavedra J (1998). Long term consumption of infant formulas with live probiotic bacteria: safety and tolerance. J Pediatr Gastroenterol Nutr 27, 484.
2. Alm L, Ryd-Kjellen E, Setterberg G, Blomquist L (1993). Effect of a new fermented milk product 'CULTURA' on constipation in geriatric patients. 1st Lactic Acid Bacteria Computer Conference Proceedings. Horizon Scientific Press: Norfolk, England.
3. Amrouche T, Boutin Y, Fliss I (2006a). Effects of bifidobacterial cytoplasm peptide and protein fractions on mouse lymphocyte proliferation and cytokine production. Food Agr Immunol 17, 29-42.
4. Amrouche T, Boutin Y, Prioult G, Fliss I (2006b). Effects of bifidobacterial cytoplasm, cell wall and exopolysaccharide on mouse lymphocyte proliferation and cytokine production. Int Dairy J 16, 70-80. (Pubitemid 41531153)
5. Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT (2005). Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis 40, 28-37. (Pubitemid 40053456)
6. Black FT, Anderson PL, Orskov J, Orskov F, Gaarslev K, Laulund S et al. (1989). Prophylactic efficacy of lactobacilli on traveler's diarrhea. Travel Med 8, 333-335.
7. Chouraqui JP, Van Egroo LD, Fichot MC (2004). Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 38, 288-292.
8. Engelbrektson AL, Korzenik JR, Sanders ME, Clement BG, Leyer G, Klaenhammer TR (2006). Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol Ecol 57, 239-250. (Pubitemid 44024913)
9. Food and Agriculture Organization of the United Nations and World Health Organization Córdoba (2001). Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Argentina.
10. Fukushima Y, Kawata Y, Hara H (1997). Effect of a probiotic formula containing bifidobacteria (Nan BF) on fecal flora and fecal metaboiltes in healthy children. Bioscience Microflora 16, 65-72.
11. Fukushima Y, Kawata Y, Hara H, Terada A, Misuoka T (1998). Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42, 39-44. (Pubitemid 28370327)
12. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L et al. (2001). Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322, 1327.
13. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001). Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 372, 1076-1079. (Pubitemid 32322538)
14. Kankaanpaa P, Sutas Y, Salmien S, Isolauri E (1998). Results on clinical demonstration of probiotics on children. Presented at Functional Food Research in Europe, Third Workshop. PROBDEMO: Finland.
15. Kekkonen RA, Lummela N, Karjalainen H, Latvala S, Tynkkynen S, Jarvenpaa S et al. (2008). Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 14, 2029-2036. (Pubitemid 351795822)
16. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF et al. (2005). Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115, 1-4.
17. Lin JS, Chiu YH, Lin NT, Chu CH, Huang KC, Liao KW et al. (2009). Different effects of probiotic species/strains on infections in preschool children: a double-blind, randomized, controlled study. Vaccine 27, 1073-1079.
18. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM (1994). Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10, 55-63. (Pubitemid 24355531)
19. Malinen E, Matto J, Salmitie M, Alander M, Saarela M, Palva A (2002). PCR-ELISA II: analysis of Bifidobacterium populations in human faecal samples from a consumption trial with Bifidobacterium lactis Bb-12 and a galacto-oligosaccharide preparation. Syst Appl Microbiol 25, 249-258. (Pubitemid 35014479)
20. marketsandmarkets.com(2009): http://www.marketsandmarkets.com/Market- Reports/probiotic-market-advanced-technologies-and-globalmarket-69.html. Probiotic Market-Advanced Technologies and Global Market (2009-2014).
21. 34+ hemopoietic precursor cell increased traffic in allergic subjects. Allerg Immunol 36, 118-122. (Pubitemid 38596005)
22. Matsumoto M, Ohishi H, Benno Y (2001). Impact of LKM512 yoghurt on improvement of intestinal environment of the elderly. FEMS Immunol Med Microbiol 31, 181-186. (Pubitemid 33086752)
23. Merenstein DJ, Foster J, D'Amico F (2009). A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study. Arch Pediatr Adolesc Med 163, 750-754.
24. Obradovic D, Curic M, Ivanovic M, Trbojevic B, Djordjevic M (1996). Probiotic function of the fermented milk Jogurt Plus. FEMS Conference (Fifth Symposium on Lactic Acid Bacteria). Holland.
25. Ouwehand AC, Kurvinen T, Rissanen P (2004). Use of a probiotic Bifidobacterium in a dry food matrix, an in vivo study. Int J Food Microbiol 95, 103-106. (Pubitemid 38881465)
26. Pedone CA, Bernabeu AO, Postaire ER, Bouley CF, Reinert P (1999). The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 53, 179-184. (Pubitemid 29201921)
27. Phuapradit P, Varavithya W, Vathanophas K, Sangchai R, Podhipak A, Suthutvoravut U et al. (1999). Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai 82 (Suppl 1), 43-48.
28. Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Pedersen P et al. (2002). Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J 21, 411-416. (Pubitemid 34532935)
29. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH (2004). Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 79, 261-267. (Pubitemid 41095979)
30. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344, 1046-1049. (Pubitemid 24310035)
31. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A (1995). Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78, 491-497.
32. StataCorp (2005). Stata Statistical Software: Release 9. StataCorp LP: College Station, TX, USA.
33. Taipale T, Pienihäkkinen K, Isolauri E, Larsen C, Brockmann E, Alanen P et al. (2011). Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr 105, 409-416.
34. Tuohy KM, Rouzaud GCM, Bruck WM, Gibson GR (2005). Modulation of the human gut microflora towards improved health using prebiotics-assessment of efficacy. Curr Pharm Des 11, 75-90. (Pubitemid 40103629)
35. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ (1999). Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135, 564-568. (Pubitemid 30180445)
36. Ventura M, Reniero R, Zink R (2001). Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Appl Environ Microbiol 67, 2760-2765. (Pubitemid 33639755)
37. Weizman Z, Asli G, Alsheikh A (2005). Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115, 5-9. (Pubitemid 43046274)